Autoimmune hemolytic anemia in an infant with giant cell hepatitis

Autoimmune hemolytic anemia (AIHA) associated with giant cell hepatitis (GCH) is a rare disorder in infants. AIHA usually precedes the development of liver disease by months to years. Early recognition of the disease and prompt institution of immunosuppressive therapy results in clinical remission a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of hematology 2006-03, Vol.81 (3), p.199-201
Hauptverfasser:	Kashyap, Rajesh, Sarangi, J.N., Choudhry, V.P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anemia, Hemolytic, Autoimmune - complications Anemia, Hemolytic, Autoimmune - drug therapy Anemia, Hemolytic, Autoimmune - pathology Anemias. Hemoglobinopathies Biological and medical sciences corticosteroid therapy Diseases of red blood cells giant cell hepatitis Giant Cells - pathology Glucocorticoids - administration & dosage Hematologic and hematopoietic diseases hemolytic anemia Hepatitis - complications Hepatitis - drug therapy Hepatitis - pathology Humans Immunoglobulins, Intravenous - administration & dosage Immunologic Factors - administration & dosage Infant Male Medical sciences Prednisone - administration & dosage Ursodeoxycholic Acid - administration & dosage
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Autoimmune hemolytic anemia (AIHA) associated with giant cell hepatitis (GCH) is a rare disorder in infants. AIHA usually precedes the development of liver disease by months to years. Early recognition of the disease and prompt institution of immunosuppressive therapy results in clinical remission and prevents liver disease progression. Am. J. Hematol. 81:199–201, 2006. © 2006 Wiley‐Liss, Inc.
ISSN:	0361-8609 1096-8652
DOI:	10.1002/ajh.20414